Studies have shown that pERK was activated in HCC patients without antiviral therapy but not in antiviral patients, indicating that antiviral treatment could reduce MVI occurrence by affecting the activation of the MAPK/ERK signalling pathway. Here, EIF2AK3 is linked to hepatocellular carcinoma.